Characteristics and risk factors for microbial infections during cancer immune checkpoint therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characteristics and risk factors for microbial infections during cancer immune checkpoint therapy

Published:2020-11-07 Issue:23 Volume:9 Page:9027-9035
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Kanjanapan Yada¹²^ORCID,Yip Desmond¹²

Affiliation:

1. Department of Medical Oncology The Canberra Hospital Garran Australia

2. ANU Medical School Australian National University Canberra Australia

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3532

Reference20 articles.

1. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

2. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

3. Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis

4. Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin’s lymphoma

5. Anti–PD-1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between immune checkpoint inhibitor and cytomegalovirus infection: A pharmacovigilance study based on the adverse event reporting system;International Journal of Cancer;2024-08-31

2. The Impact of Infections in Patients Treated with Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma;Journal of Clinical Medicine;2024-08-23

3. Tailoring Phage Nanosomes for Enhanced Theranostic Properties of Near Infrared Dyes;Langmuir;2024-07-29

4. Cancer immunotherapy with immune checkpoint inhibitors and infections: A particular focus on mycobacterial infections;Respiratory Investigation;2024-05

5. Infection-related Hospitalizations During Immune Checkpoint Inhibitor Treatment Without Immunosuppressants;Journal of Immunotherapy;2024-01-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3